
Thomas Sweeney Heard
Examiner (ID: 8001, Phone: (571)272-2064 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 1286 |
| Issued Applications | 710 |
| Pending Applications | 90 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17451876
[patent_doc_number] => 11266713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Di-sulfide containing cell penetrating peptides and methods of making and using thereof
[patent_app_type] => utility
[patent_app_number] => 16/348706
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 31582
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348706
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348706 | Di-sulfide containing cell penetrating peptides and methods of making and using thereof | Nov 8, 2017 | Issued |
Array
(
[id] => 17451876
[patent_doc_number] => 11266713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Di-sulfide containing cell penetrating peptides and methods of making and using thereof
[patent_app_type] => utility
[patent_app_number] => 16/348706
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 31582
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348706
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348706 | Di-sulfide containing cell penetrating peptides and methods of making and using thereof | Nov 8, 2017 | Issued |
Array
(
[id] => 17451876
[patent_doc_number] => 11266713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Di-sulfide containing cell penetrating peptides and methods of making and using thereof
[patent_app_type] => utility
[patent_app_number] => 16/348706
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 31582
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348706
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348706 | Di-sulfide containing cell penetrating peptides and methods of making and using thereof | Nov 8, 2017 | Issued |
Array
(
[id] => 15147773
[patent_doc_number] => 20190352364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => MANP Analogues
[patent_app_type] => utility
[patent_app_number] => 16/348652
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348652
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348652 | MANP analogues | Nov 8, 2017 | Issued |
Array
(
[id] => 17451876
[patent_doc_number] => 11266713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Di-sulfide containing cell penetrating peptides and methods of making and using thereof
[patent_app_type] => utility
[patent_app_number] => 16/348706
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 31582
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348706
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348706 | Di-sulfide containing cell penetrating peptides and methods of making and using thereof | Nov 8, 2017 | Issued |
Array
(
[id] => 14712791
[patent_doc_number] => 20190247459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => ANTIMICROBIAL COMPOSITION COMBINATIONS COMPRISING STAR SHAPED PEPTIDE POLYMERS
[patent_app_type] => utility
[patent_app_number] => 16/343556
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343556
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343556 | Antimicrobial composition combinations comprising star shaped peptide polymers | Nov 1, 2017 | Issued |
Array
(
[id] => 14665041
[patent_doc_number] => 10370411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Beta-hairpin peptidomimetics
[patent_app_type] => utility
[patent_app_number] => 15/791087
[patent_app_country] => US
[patent_app_date] => 2017-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18555
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15791087
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/791087 | Beta-hairpin peptidomimetics | Oct 22, 2017 | Issued |
Array
(
[id] => 12177432
[patent_doc_number] => 20180036367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN'
[patent_app_type] => utility
[patent_app_number] => 15/789442
[patent_app_country] => US
[patent_app_date] => 2017-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 43169
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15789442
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/789442 | METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN | Oct 19, 2017 | Abandoned |
Array
(
[id] => 12606597
[patent_doc_number] => 20180094029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => METHODS OF TREATING OPHTHALMIC DISEASES USING NPR-B AGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/786843
[patent_app_country] => US
[patent_app_date] => 2017-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15786843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/786843 | METHODS OF TREATING OPHTHALMIC DISEASES USING NPR-B AGONISTS | Oct 17, 2017 | Abandoned |
Array
(
[id] => 15451389
[patent_doc_number] => 20200038518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => Mitochondrially Targeted PARP Inhibitor, and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/340237
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340237
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/340237 | Mitochondrially targeted PARP inhibitor, and uses thereof | Oct 12, 2017 | Issued |
Array
(
[id] => 15800111
[patent_doc_number] => 20200123198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => Peptide Libraries and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 16/339189
[patent_app_country] => US
[patent_app_date] => 2017-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339189 | Peptide Libraries and Methods of Use | Oct 2, 2017 | Abandoned |
Array
(
[id] => 16282668
[patent_doc_number] => 20200276270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => Combination Therapy with Controlled-Release CNP Agonists
[patent_app_type] => utility
[patent_app_number] => 16/338185
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338185
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338185 | Combination therapy with controlled-release CNP agonists | Sep 27, 2017 | Issued |
Array
(
[id] => 17874363
[patent_doc_number] => 11446355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance
[patent_app_type] => utility
[patent_app_number] => 16/336334
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11491
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336334
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/336334 | Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance | Sep 25, 2017 | Issued |
Array
(
[id] => 12584964
[patent_doc_number] => 20180086817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Preventing, Treating or Arresting Alzheimer's, Stroke, Cardiovascular and other Amyloid Related Diseases
[patent_app_type] => utility
[patent_app_number] => 15/712985
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -73
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15712985
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/712985 | Preventing, Treating or Arresting Alzheimer's, Stroke, Cardiovascular and other Amyloid Related Diseases | Sep 21, 2017 | Abandoned |
Array
(
[id] => 12637332
[patent_doc_number] => 20180104274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => POLYPEPTIDE HAVING THE CAPACITY TO FORM ALPHA-1,3 GLUCOSYL UNIT BRANCHINGS ON AN ACCEPTOR
[patent_app_type] => utility
[patent_app_number] => 15/712173
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15712173
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/712173 | Polypeptide having the capacity to form alpha-1,3 glucosyl unit branchings on an acceptor | Sep 21, 2017 | Issued |
Array
(
[id] => 16876813
[patent_doc_number] => 11026933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Compositions and methods for treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 16/332404
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 11338
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332404
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332404 | Compositions and methods for treatment of cancer | Sep 19, 2017 | Issued |
Array
(
[id] => 14581281
[patent_doc_number] => 20190218249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => A PROCESS FOR PURIFICATION OF CARFILZOMIB INTERMEDIATE
[patent_app_type] => utility
[patent_app_number] => 16/332717
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332717
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332717 | Process for purification of carfilzomib intermediate | Sep 12, 2017 | Issued |
Array
(
[id] => 14406795
[patent_doc_number] => 20190169241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => KIF13B-DERIVED PEPTIDE AND METHOD OF INHIBITING ANGIOGENESIS
[patent_app_type] => utility
[patent_app_number] => 16/325006
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325006
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/325006 | KIF13B-derived peptide and method of inhibiting angiogenesis | Aug 30, 2017 | Issued |
Array
(
[id] => 13702695
[patent_doc_number] => 20170362302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => Method and Pharmaceutical Composition for Use in the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 15/687692
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13538
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/687692 | Method and Pharmaceutical Composition for Use in the Treatment of Cancer | Aug 27, 2017 | Abandoned |
Array
(
[id] => 16246110
[patent_doc_number] => 10745451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Scorpion toxin fusion protein with enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle, enhancing skin elasticity and anti-aging comprising the same as an effective ingredient
[patent_app_type] => utility
[patent_app_number] => 16/328107
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 6481
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328107 | Scorpion toxin fusion protein with enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle, enhancing skin elasticity and anti-aging comprising the same as an effective ingredient | Aug 24, 2017 | Issued |